←Back to Expert Scholars
Translational Medicine / 转化医学Uveal Melanoma
Richard Carvajal
MD
🏢Northwell Health Cancer Institute🌐USA
Deputy Physician in Chief
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Richard Carvajal led pivotal trials of tebentafusp that transformed outcomes for HLA-A*02:01 positive metastatic uveal melanoma. His work establishes the first survival improvement in this rare cancer. He is a leading clinical investigator for uveal melanoma therapy.
Share:
🧪Research Fields 研究领域
uveal melanoma
tebentafusp
bispecific T cell engager
clinical trials
metastatic melanoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Richard Carvajal 的研究动态
Follow Richard Carvajal's research updates
留下邮箱，当我们发布与 Richard Carvajal（Northwell Health Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment